Blog From Paperwork to Persistence: Measuring the Value of Consent October 13, 2026 When consent is captured early and made available across the ecosystem, do patients actually do better? Read More
Blog The Hidden Compliance Gap That’s Slowing Down Patient Access September 21, 2026 Patient consent management rarely gets the spotlight in market access conversations. It doesn’t have the urgency of coverage denials or… Read More
Blog Top 10 Things to Know Before Implementing a Patient Services CRM August 12, 2026 When Tricia Sterling, Executive Director of Patient Experience, described her first CRM implementation in one word, she didn’t hesitate: “a… Read More
Blog The Best Specialty Patient Journey Platform for Biopharma in 2026 July 27, 2026 If you’re leading market access or commercial analytics at a biopharma company, you already know how difficult it can be… Read More
Blog Buy and Bill in Oncology: Why Limited Data Doesn’t Have to Mean Limited Visibility July 23, 2026 Few specialties challenge the buy-and-bill model the way oncology does. Infused and injectable therapies flow through hospitals, clinics, and physician… Read More
Blog The Best Patient Consent Management Solution for Specialty Biopharma in 2026 June 24, 2026 Every specialty pharmacy in your network collects patient consent. Almost none of them collect it the same way. Different forms,… Read More
Blog Four Themes Shaping the Specialty Analytics Stack – AXS26 Recap May 15, 2026 The Claritas Rx product team spent three days at this year's annual specialty pharmacy conference, walking the exhibit floor, attending sessions across the AI, patient… Read More
Blog Ask Ascend: An AI Chatbot That Puts Scorecard Insights at Your Fingertips May 6, 2026 Ask Ascend is an AI-powered chatbot that lets business users explore data using natural language—no SQL or technical expertise required. Read More
Blog Turning Rare Disease Data into Action: How AI is Changing the Game February 27, 2026 Rare diseases affect approximately 30 million people in the United States, yet the path to diagnosing and treating these conditions remains notoriously… Read More
Blog Top Specialty Pharma Leaders Reshaping the Rare Disease Market February 19, 2026 The rare disease market has evolved from a fragmented collection of niche therapies into one of the most strategically important… Read More
Blog Rare Disease: From Niche Bet to Strategic Imperative for Specialty Pharma February 10, 2026 Rare disease has evolved from a niche scientific experiment into a core growth engine for specialty pharma. But that model… Read More
Blog Turning Cell and Gene Therapy Complexity into Clarity: Data, Collaboration, and Patient Impact February 9, 2026 There’s no denying that cell and gene therapies (CGTs) are shaping the future of medicine and healthcare as we know it. The global CGT… Read More
Blog When Rare Isn’t Rare: A Snapshot of the Global Rare Disease Burden February 2, 2026 The Global and Personal Burden of Rare Diseases Rare diseases collectively affect hundreds of millions of people worldwide, yet each… Read More